Kenneth McDonnell

Chief Financial Officer
US-Japan Medtech Frontiers



Ken’s extensive involvement in the commercialization of disruptive medical technologies for startups to multinationals provides him with a broad perspective on the scope, process and scale for device innovation. Prior to joining USJMF, Ken served as the General Manager, Business Development for Terumo Medical Corporation, the U.S. subsidiary of the Terumo Corporation, since 2004. Before joining Terumo, Ken held senior management positions at several early-stage ventures addressing large, underserved medical conditions, such as the intravascular identification of atherosclerotic “vulnerable plaque” (InfraReDx); ultra-high speed ultrasound imaging for the early detection of myocardial impairment (Diasonics-Vingmed); cerebral monitoring for the detection of perioperative events that can lead to stroke (MedaSonics/Neuroguard); screening for hearing loss in newborns (Natus); and oxygen saturation monitoring for the prevention of perioperative hypoxemia (Nellcor). Ken began his medical device career with Corning Medical.

Current and past board positions include USJMF, Provisio Medical, Enterprise Ireland LifeSciences Advisory Council, Terumo Medical Innovations, and MicroVention Terumo.

Ken received a BS in Human Biology from the University of Notre Dame, and an MBA from the University of Washington.